申请人:F. Hoffmann-La Roche AG
公开号:EP3623369A1
公开(公告)日:2020-03-18
The present invention relates to compounds of formula (I),
wherein R1, R2 and R3 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
本发明涉及式(I)的化合物,其中R1、R2和R3如本文所述,并且涉及其药用可接受的盐、对映体或二对映体,以及包括这些化合物的组合物和使用这些化合物的方法。